GRI Bio GRI
NASDAQ GRI
$1.45 +0.02 (+1.40%)
At close: Oct 23, 2026 · 4:00 PM EDT

GRI Bio (GRI) Amortization of Deferred Charges (2020 - 2023)

Updated

Analysis

GRI Bio (GRI) Amortization of Deferred Charges (2020 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 GRI Bio 2.63 Mn -31.65 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 1.16 Mn
Mar 31, 2023 1.16 Mn
Dec 31, 2022 172,000.00
Sep 30, 2022 45,000.00
Jun 30, 2022 -19,000.00
Mar 31, 2022 19,000.00
Dec 31, 2021 18,000.00
Sep 30, 2021 19,000.00
Jun 30, 2021 18,000.00
Mar 31, 2021 18,000.00
Dec 31, 2020 19,000.00
Sep 30, 2020 18,000.00
Jun 30, 2020 19,000.00
Mar 31, 2020 18,000.00
API Access

GRI Bio Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=GRI&period=max&api_key=YOUR_API_KEY